Skip to content
← Full study record

NCT00619645 · MORE INFO

Limitations, agreements, and source contact

Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers · Source last updated 2018-01-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
limitations And Caveats
description
This study was closed after only enrolling 8 patients and results were never published.
point Of Contact
email
nmahaffey@ucdavis.edu
organization
University of California Davis
phone
916-734-8381
title
Data Manager
Complete source fields
certain Agreement
pi Sponsor Employee
true
limitations And Caveats
description
This study was closed after only enrolling 8 patients and results were never published.
point Of Contact
email
nmahaffey@ucdavis.edu
organization
University of California Davis
phone
916-734-8381
title
Data Manager

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice